Apocrine Carcinoma, Adenopathies, and Raised TAG-72 Serum Tumor Marker

Dermatologic Surgery

Volumn 30, Issue 4 I, 2004, Pages 566-569

  Santos Juanes, Jorge ^a   De Quirós, José Francisco Bernaldo ^a   Osuna, Cristina Galache ^a   Del Río, José Sánchez ^a   Allende, María Teresa ^a   Folgueras, María Victoria ^a   De Delás, Jorge Soto ^b  

^a Hospital de Asturias   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; TAG 72 ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ANTIBODY BLOOD LEVEL; APOCRINE CARCINOMA; ARTICLE; AXILLARY LYMPH NODE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; CONCENTRATION RESPONSE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MARKER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPHADENOPATHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BIOPSY;

AGED; ANTIGENS, NEOPLASM; APOCRINE GLANDS; AXILLA; CARCINOMA; GLYCOPROTEINS; HUMANS; LYMPHATIC DISEASES; LYMPHATIC METASTASIS; MALE; SENSITIVITY AND SPECIFICITY; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 1942498962     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30180.x     Document Type: Article

References (15)

1. Katagiri Y, Ansai S. Two cases of cutaneous apocrine ductal carcinoma of the axilla. Dermatology 1999;199:332-7.
2. Zehr KJ, Rubin M, Ratner LL. Apocrine adenocarcinoma presenting as a large ulcerated axillary mass. Dermatol Surg 1997;23:585-7.
3. Yoshida A, Kodama Y, Hatanaka S, et al. Apocrine adenocarcinoma of the bilateral axillae. Acta Pathol Jpn 1991;41:927-32.
4. Colcher D, Horan Hand P, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981;78:3199-203.
5. Muraro R, Kuroki D, Wunderlich D, et al. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor associated glycoprotein 72 antigen. Cancer Res 1988;48:4588-96.
6. Filella X, Molina R, Jo J, et al. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease. Bull Cancer 1992;79:271-7.
7. Requena L, Kiryu H, Ackerman AB. Ductal Carcinoma. In: Reguena L, Kiryu H, Ackerman AB, eds. Neoplasms with apocrine differentiation. Philadelphia: Lippincott-Raven, 1998.
8. Guadagni F, Roselli M, Ferroni P, et al. Clinical value of the TAG-72 tumor marker in the management of carcinoma patients. In: Ballesta A, Torre GC, Bombardieri E, Gion M, Molina R, eds. Updating on Tumor Markers in Tissues and in Biological Fluids: Basic Aspects and Clinical Application. Torino: Edizioni Minerva Medica, 1993:555-68.
9. Gero EJ, Colcher D, Ferroni P, et al. CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma associated antigen in serum of patients. J Clin Lab Anal 1989;3:360-9.
10. López JB, Royan GP, Lakhwani MN, et al. CA 72-4 compared with CEA and CA 19.9 as a marker of some gastrointestinal malignancies. Int J Biol Markers 1999;14:172-7.
11. Guadagni F, Roselli M, Cosimelli M, et al. TAG-72 Expression and its role in the biological evaluation of human colorectal cancer. Anticancer Res 1996;18:2141-8.
12. Tavassoli FA, Jones MW, Majeste RM, et al. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease. Am J Surg Pathol 1990;14:128-33.
13. Soomro S, Shousha S. Monoclonal antibody B72.3 in benign breast lesions. J Clin Pathol 1990;43:1026-8.
14. Paties C, Taccagni L, Papotti M, et al. Apocrine carcinoma of the skin. Cancer 1993;71:375-81.
15. Tsubura A, Senzaki H, Sasaki M, Hilgers J, Morii S. Immunohistochemical demonstration of breast derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Curan Pathol 1992;19:73-9.